It will be shown in the appendix 5B as cash when the long-form loan agreement is signed.
'Conditional' can be misinterpreted. RNU has credit approval, otherwise they would not be moving to long-form loan agreement, which is based on the term sheet detailing T&Cs of the loan. Even without binding offtakes.
What is remaining is really administrative in nature (due diligence, Conditions Precedent) and legal work in putting the term sheet into proper loan agreement legal format. Technical due diligence (I think would be most important dd item) has been completed and no fatal-flaws found. Given its 1 lender and 1 borrower and RNU this remaining process to signing of loan agreement should be relatively straight-forward 2 months max, particularly as dd has been running concurrently for last couple of months.
I believe that a Condition Precedent of any loan drawdown of the already signed loan agreement and in force loan facility, will be FID and binding offtake (the latter not an absolute).
This is my take on it anyway.....
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
It will be shown in the appendix 5B as cash when the long-form...
-
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RNU (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $180.4M |
Open | High | Low | Value | Volume |
7.1¢ | 7.1¢ | 7.0¢ | $251.1K | 3.567M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 834089 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.1¢ | 118655 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 834089 | 0.070 |
10 | 612579 | 0.069 |
6 | 339703 | 0.068 |
5 | 854551 | 0.067 |
4 | 425451 | 0.066 |
Price($) | Vol. | No. |
---|---|---|
0.071 | 118655 | 7 |
0.072 | 465890 | 4 |
0.073 | 554761 | 7 |
0.074 | 750000 | 4 |
0.075 | 170348 | 4 |
Last trade - 14.26pm 12/11/2024 (20 minute delay) ? |
Featured News
RNU (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online